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Background: A high dose of anti-infective agents is recommended when treating infectious meningitis. High
creatinine clearance (CrCl) may affect the pharmacokinetic / pharmacodynamic relationships of anti-infective drugs
eliminated by the kidneys. We recorded the incidence of high CrCl in intensive care unit (ICU) patients admitted
with meningitis and assessed the diagnostic accuracy of two common methods used to identify high CrCl.
Methods: Observational study performed in consecutive patients admitted with community-acquired acute
infectious meningitis (defined by >7 white blood cells/mm3 in cerebral spinal fluid) between January 2006 and
December 2009 to one medical ICU. During the first 7 days following ICU admission, CrCl was measured from 24-hr
urine samples (24-hr-UV/P creatinine) and estimated according to Cockcroft-Gault formula and the simplified
Modification of Diet in Renal Disease (MDRD) equation. High CrCl was defined as CrCl >140 ml/min/1.73 m2 by
24-hr-UV/P creatinine. Diagnostic accuracy was performed with ROC curves analysis.
Results: Thirty two patients were included. High CrCl was present in 8 patients (25%) on ICU admission and in 15
patients (47%) during the first 7 ICU days for a median duration of 3 (1-4) days. For the Cockcroft-Gault formula, the
best threshold to predict high CrCl was 101 ml/min/1.73 m2 (sensitivity: 0.96, specificity: 0.75, AUC= 0.90 ± 0.03) with
a negative likelihood ratio of 0.06. For the simplified MDRD equation, the best threshold to predict high CrCl was
108 ml/min/1.73 m2 (sensitivity: 0.91, specificity: 0.80, AUC= 0.88 ± 0.03) with a negative likelihood ratio of 0.11.
There was no difference between the estimated methods in the diagnostic accuracy of identifying high CrCl
(p = 0.30).
Conclusions: High CrCl is frequently observed in ICU patients admitted with community-acquired acute infectious
meningitis. The estimated methods of CrCl could be used as a screening tool to identify high CrCl.
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The glomerular filtration rate (GFR) can affect the
pharmacokinetic/pharmacodynamic relationships of drugs
eliminated by the kidney. The dosages and intervals of
administration of these drugs are routinely adjusted in
patients with a diminished GFR to achieve effective
treatment and to limit drug-induced toxicity. GFR is* Correspondence: alautrette@chu-clermontferrand.fr
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reproduction in any medium, provided the orcurrently estimated in clinical practice by creatinine clear-
ance (CrCl). CrCl is recommended in most textbooks and
guidelines to decide on the dosage of drugs with kidney
clearance for patients with renal insufficiency. In most
studies CrCl is measured from 24-hour urine samples
(24-hr-UV/P creatinine) or estimated according to
Cockcroft-Gault formula and the simplified Modification
of Diet in Renal Disease (MDRD) equation [1].
High CrCl has been reported in groups of intensive
care unit (ICU) patients in the post-operative setting [2],
and in patients with burns [3] or suffering from cerebral
lesions [4]. In patients admitted to the ICU withal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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adequate anti-infective treatment is mandatory and high
drug dosage administration is advocated [5] to achieve
effective anti-infective agent concentrations in the cere-
bral spinal fluid (CSF). Some of these anti-infective
agents undergo kidney clearance. However, the presence
of high CrCl in this group of patients is particularly
interesting because it may allow the physician to adopt
specific anti-infective dosing strategies and thereby avoid
treatment failure and drug-induced resistance [6]. The
major aim of the study was to record the rate of high
CrCl, calculated by 24-hr UV/P creatinine, in patients
admitted to the ICU with community-acquired infec-
tious meningitis. The secondary aim was to assess the
accuracy of Cockcroft-Gault formula and the simplified
MDRD equation in identifying high CrCl.
Methods
Study patients
We reviewed the charts of all consecutive patients
older than 18 years admitted between January 2006
and December 2009 to the 9-bed medical ICU of the
University Hospital of Clermont-Ferrand (France) for
community-acquired acute infectious meningitis. A com-
puterized search tool was used to identify patients from
the hospital discharge diagnostic database. Meningitis was
defined by CSF pleocytosis > 7 white blood cells × 106/L, as
proposed by other investigators [7]. Patients with menin-
gitis due to a documented non-infectious cause or that
had occurred during hospitalization or within one week
after discharge were excluded. Patient characteristics,
clinical features, results of investigations, treatment,
and outcome were extracted from medical records.
The item “diabetes” corresponded to patients receiv-
ing a specific medication for diabetes before hospital
admission. The Simplified Acute Physiology Score
(SAPS) II score and the Sequential Organ Failure
Assessment (SOFA) score on the admission-day were
calculated from the charts.
Assessment of creatinine clearance
In our ICU, the patient’s weight, 24-hour urine output,
serum and urine creatinine levels are daily measured as
standard practice. All serum creatinine samples are mea-
sured by the hospital biochemistry laboratory, using a
compensated Jaffe method (Modular P, Roche Diagnos-
tics GmbH, Mannheim, Germany). No change in clinical
practice was made during the study period. CrCl was
determined daily during the first 7 days of ICU stay by
one measured method, 24-hr-UV/P creatinine, and two
estimated methods, Cockcroft-Gault formula and the
simplified MDRD equation (Additional file 1: Table S1)
[1]. The CrCl measured by 24-hr UV/P creatinine and
estimated by Cockcroft’s equation was normalized bybody surface area, as recommended by KDOQI guide-
lines [1]. The height and weight used for calculation of
body surface area were measured on ICU admission.
The patients’ height and weight were measured in a su-
pine position with a tape measure and a Hill–Rom bed
(Medicraft, Marrickville NSW, Australia), respectively.
High CrCl was defined as CrCl >140 ml/min/1.73 m2 by
24-hr-UV/P creatinine.
Statistical analysis
High CrCl was expressed as incidence, in which the nu-
merator is the number of patients with at least one
measurement of high CrCl and the denominator the
overall number of patients. The percentage of days with
a high CrCl during the first 7 days of ICU stay was
expressed as duration ratio, in which the numerator is
the total number of days with high CrCl and the denom-
inator the total number of ICU days of the overall popu-
lation. High CrCl incidence and duration ratio were
therefore expressed as a percentage. Continuous vari-
ables, presented as mean ± SD or as median (IQR), were
compared by Mann–Whitney U test. Categorical vari-
ables were compared by Fisher’s exact test.
For comparisons between measurements methods, we
built a Bland-Altman plot between differences and
averages seeking possible biases and outliers. The diag-
nostic accuracy of Cockcroft-Gault formula and the sim-
plified MDRD equation in predicting high CrCl was
then assessed by measuring the area under the receiver
operating characteristic (ROC) curves. Each measure
was treated as an independent event. The areas under
the ROC curves were compared by the Wilcoxon rank
test. The best threshold with their corresponding likeli-
hood ratios (negative and positive) was defined by
Youden’s index. Statistical tests were performed with
the SAS program except for the AUC, which was
assessed by Medcalc. A value of p < 0.05 was considered
to be significant.
Results
During the study period, 1266 patients were admitted to
the ICU. Of these, 32 had community-acquired acute in-
fectious meningitis. No cases were excluded because of
missing data. The characteristics of the patients and the
causative organisms of meningitis are shown in Tables 1
and 2, respectively. In 18 patients bacterial or fungal
meningitis was diagnosed by a positive CSF culture, and
in 2 patients viral meningitis was diagnosed by a positive
CSF viral polymerase chain reaction test result. In 12
patients the diagnosis of community-acquired acute in-
fectious meningitis was considered in spite of the ab-
sence of a causative organism. Of these, 7 were receiving
antibiotics prior to lumbar puncture. In the 12 patients,
the mean CSF glucose level, protein level and white
Table 1 Characteristics of the patients
Characteristics N =32
Gender ratio (men/women) 15/17
Age, yrsa,b 54 ± 16
Weight, kga,b 71 ± 25
Height, cma,b 166 ± 11
Body surface area, m2, a,b 1.77 ± 0.27
Diabetes, n (%)b 6 (19)
SAPSII, ptsa,b 46 ± 19
SOFA, ptsa,b 7 ± 4
Neurologic SOFA, ptsa,b 2 ± 1
Mechanical ventilation, n (%)c 22 (69)
Vasopressive drug, n (%)c 13 (41)
Renal replacement therapy, n (%)c 3 (9)
ICU length of stay, daysd 13 (8-19)
ICU mortality, n (%) 4 (12)
a: mean ± SD; b: on ICU admission; c: during ICU stay ; d: median (IQR).
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47 ± 53 × 106/L, respectively.
The incidence of high CrCl was 47% (15/32) during the
7-day study period, and the duration ratio was 26%. On
ICU admission, the frequency of high CrCl was 25% (8/32).
The daily frequency of high CrCl was unchanged through-
out the first 7 days of ICU stay, (P=0.60) (Figure 1). Except
for SAPS II on admission, there were no differences in the
characteristics of the population upon admission and dur-
ing ICU stay irrespective of the presence or absence of high
CrCl (Additional file 2: Tables S2 and Additional file 3:
Table S3).
For the diagnosis of high CrCl, the area under the
ROC curves of Cockcroft-Gault formula was 0.90 ± 0.03
and the simplified MDRD equation was 0.88 ± 0.03.
Between Cockcroft-Gault formula and the simplifiedTable 2 Causative organisms of meningitis
N=32
Bacteria
Streptococcus pneumoniae, n 9
Other strepotococci, n 3
Staphylococcus aureus, n 2
Mycobacterium Tuberculosis, n 1
Escherichia coli, n 1
Virus
Herpes virus type 6, n 1
Cytomegalovirus, n 1
Parasite
Cryptococcus neoformans, n 2
Indeterminate, n 12MDRD equation, there was no difference in the diag-
nostic accuracy identifying high CrCl (P = 0.30). For
Cockcroft-Gault formula, the best threshold was
101 ml/min/1.73 m2, corresponding to a sensitivity of
96% and a specificity of 75%. For the simplified MDRD
equation, the best threshold was 108 ml/min/1.73 m2
with a sensitivity of 91% and a specificity of 80%. Bias,
as illustrated by the mean difference in the Bland and
Altman analysis between 24-hr-UV/P creatinine and
Cockcroft-Gault formula and between 24-hr-UV/P cre-
atinine and the simplified MDRD equation was 0.9
and −3.1 ml/min/1.73 m2 respectively. The differences,
as illustrated by the ± 95% fluctuation interval in the
Bland–Altman graphs, between 24-hr-UV/P creatinine
and Cockcroft-Gault formula and between 24-hr-UV/P
creatinine and the simplified MDRD equation were −99.7
to 101.4 ml/min/1.73 m2 and −113.1 to 106.9 ml/min/
1.73 m2, respectively (Additional file 4: Figures S1A-B).
Four of the 44 measurements with high CrCl had a value
of simplified MDRD equation under the threshold of
108 ml/min/1.73 m2 from ROC curve analysis (Figure 2).
The likelihood ratio of a negative result was 0.11,
meaning that the odds of high CrCl is 10 times smal-
ler when the value of simplified MDRD equation is
under the threshold of 108 ml/min/1.73 m2.
Of the 44 measurements with high CrCl, 2 had a
value of Cockcroft-Gault formula under the threshold
of 101 ml/min/1.73 m2 from ROC curve analysis
(Figure 3). The likelihood ratio of a negative result
was 0.06, meaning that the odds of high CrCl is more
than 10 times smaller when the value of Cockcroft-
Gault formula is under the threshold of 101 ml/min/
1.73 m2. There was no difference in the 15% and
30% accuracy between Cockcroft-Gault formula and
the simplified MDRD equation for diagnosing high
CrCl, 36% vs 20% (P = 0.17) and 68% vs 52%,





















Figure 1 Evolution of the daily frequency of high CrCl in
patients with community-acquired acute infectious meningitis.
Black box, number of patients with high CrCl. White box, number of
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Figure 2 Distribution of creatinine clearance values performed with simplified MDRD equation according of the diagnosis of high CrCl.
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Our study showed that high CrCl is often seen on ad-
mission in ICU patients with community-acquired acute
infectious meningitis. It can persist for several days and
be predicted by the estimated methods.
CrCl is classically screened for GFR despite limitations.
Creatinine is metabolised and secreted by the renal tu-
bule, and hence CrCl both overestimates the GFR and
delays the diagnosis of acute kidney injury. Inulin clear-
ance is the gold standard test for accurately measuring
GFR. However it is complex to perform, highly expen-
sive, and cannot therefore be routinely used in ICU
patients. Iohexol clearance is an alternative to estimating














































Figure 3 Distribution of creatinine clearance values performed with Cprecludes its sequential and repeated use in patients and
in healthy volunteers. In clinical practice, despite its lim-
itations, CrCl is currently used to estimate GFR because
it is inexpensive, harmless, and easy to perform, particu-
larly in ICU patients. Moreover, it is now well estab-
lished that small plasma creatinine variations are
independently associated with poor prognosis in ICU
patients [8], reinforcing the widespread measurement of
plasma creatinine for the diagnosis and follow up of kid-
ney function in these patients.
There is no consensus on what constitute normal GFR
values, but most authors consider them to range be-
tween 90 and 130 ml/min/1.73 m2 [9]. Similarly, the
normal values of CrCl are not agreed upon and most101 ml/min/1.73m
No high CrCl 
²
ockcroft-Gault formula according of the diagnosis of high CrCl.
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Several threshold values have been used to define high
CrCl, ranging from 120 ml/min/1.73 m2 to 150 ml/
min/1.73 m2 for women and 160 ml/min/1.73 m2 for
men [10-13]. In light of all these factors, we chose a
140 ml/min/1.73 m2 threshold to define high CrCl.
This probably allows a greater specificity in the diagno-
sis of high CrCl than in most studies. We made no dis-
tinction between male and female patients since gender
entails no difference in treatment, in particular with re-
gard to dosage. Cockcroft-Gault formula and simplified
MDRD equation are commonly used to determine CrCl
because diuresis quantification and urinary creatinine
measurement are not necessary in the equations.
Hence, estimation of CrCl by these two methods is
simpler than calculation by 24-hr UV/P creatinine.
CrCl as estimated from equations has been recom-
mended for dosage adjustment in patients with reduced
kidney function receiving antibiotics with renal elimin-
ation. However, no consensus firmly states which meth-
ods must be used in ICU patients to determine CrCl.
In our study we defined high CrCl as clearance above
140 ml/min/1.73 m2 by 24-hr UV/P creatinine. As
reported elsewhere, our results demonstrate that CrCl
calculated with the 24-hr UV/P creatinine and esti-
mated from equations may yield different results
[3,12,14]. Baptista et al. reported that in patients with
augmented CrCl, the estimated methods of CrCl sig-
nificantly under-estimate the measured value of the cal-
culated method [12]. Our findings are in agreement
with previously published data and suggest that the
estimated methods of CrCl could be used as a screen-
ing tool to diagnose high CrCl with a 101 ml/min/
1.73 m2 threshold for Cockcroft-Gault formula and a
108 ml/min/1.73 m2 threshold for simplified MDRD
equation. The simplified MDRD equation and the
Cockcroft-Gault formula make it possible to rule out a
high CrCl when their values are under their respective
thresholds.
There is a paucity of information in the literature re-
lating to the characteristics of high CrCl in ICU patients.
The incidence of high CrCl in a general population of
ICU patients can vary between 18% [11] and 41% [12].
The main factors associated with high CrCl in these
studies are young age, greater body surface area, higher
diastolic blood pressure, diuresis levels, lower APACHE
III scores at admission and multiple trauma [10,11]. In a
small sample of patients with head trauma, the incidence
of high CrCl was 85% [13]. In addition, some studies
that did not specifically deal with high CrCl but either
with the assessment of renal function in particular ICU
patient groups (burns, trauma, brain injury, surgery)
[2-4,10], or with the pharmacokinetic and pharmacody-
namic properties of antibiotics [15-18], recorded anincidence of high CrCl ranging from 3% to 50% and
values between 130 and 200 ml/min/1,73 m2.
Little is known about the pathological mechanisms of
high CrCl in ICU patients. The condition has been
reported during pregnancy, following nephrectomy, at
the onset of diabetic kidney disease, in obesity, in sickle
cell anaemia [19] and in children with haemopathy [20].
It has been suggested that high CrCl occurs as a result
of glomerular hyperperfusion [21]. Experimental studies
have shown that high CrCl is observed during the initial
hyperkinetic phase of sepsis [22,23]. However, this hy-
pothesis cannot account for all cases of high CrCl in
acute or chronic situations. Another suggested explan-
ation for high CrCl when it is detected at the onset of
diabetic kidney disease is that hyperglycaemia stimulates
the re-absorption of sodium in the proximal tubule
thereby decreasing its supply to the distal tubule. This
would set off tubuloglomerular feedback in the macula
densa and result in dilatation of the afferent arteriole
and an increase in GFR [24]. A third explanation, in par-
ticular in children with malignancies and in obese
patients is that high CrCl is due to the kidney adjusting
to the high protein load caused by large tumours [20] or
to the hypermetabolism brought on by obesity [25]. No
single hypothesis of the above three seems to explain the
high CrCl observed in our study, and it is likely that sev-
eral mechanisms occur in combination.
In drugs with kidney clearance, a decrease or increase
in normal GFR can have a major impact on its plasma
concentration. Lowered GFR impairs elimination of the
drug and can lead to excessively high concentrations if
the dosage is not decreased or if the intervals between
doses are not lengthened. Drug overdosage can have ser-
ious side effects resulting in increased morbidity [15,26]
and for this reason there are dosage guidelines to be fol-
lowed in the event of a decrease in GFR. Conversely,
high GFR can lead to greater concentrations of the drug
being eliminated with the possible risk of insufficient
dosage and hence treatment failure or, in the case of
antibiotics, the emergence of resistant bacteria. There
are currently no guidelines for adjusting drug dosage
when GFR is high. Our study is not able to assess the
pharmacokinetic or pharmacodynamic effects of a drug
during high CrCl. Assessments of these effects elsewhere
have shown that there is a close connection between the
plasma concentration of a drug and CrCl and that, for
example, high CrCl is associated with low plasma con-
centrations of the drug [15,16,27-29]. This suggests that
high CrCl could lower drug concentration to a level that
renders it therapeutically ineffective, despite a seemingly
appropriate dosage. No study has shown a causal rela-
tion between high CrCl and failure of drug treatment.
Our study shows that high CrCl can persist for several
days. It is possible that when high CrCl lasts only a few
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period of high CrCl would probably require daily dosage
adjustment. It would be interesting to perform a daily
monitoring of the presence and intensity of high CrCl in
patients taking drugs excreted by the kidneys.
Our study has several limitations. First, it was retro-
spective and therefore we cannot rule out the possibility
that certain eligible patients were excluded because of
an oversight in the computer rating of diagnosis of men-
ingitis. However, the main outcome criterion, the inci-
dence of high CrCl, did not influence the selection of
the patients recruited. Second, it was a monocentric
study including only ICU patients admitted for meningi-
tis, and so extrapolating the results to a general ICU
population remains speculative. The study was focused
on patients with meningitis, since in this clinical situ-
ation, prompt antiinfectious treatment with both ad-
equate agent and dosage is mandatory for preventing
poor outcome. High CrCl may impact the pharmacokin-
etics of the drugs resulting in therapeutic failure due to
low drug concentration despite an apparent appropriate
drug dosage. Third, the diagnosis of meningitis was
based on CSF white cell count, and therefore may have
been overestimated. However, this diagnostic criterion is
classically used in studies on meningitis in ICU patients
and the magnitude of the results would not have been
different if we had limited the study to patients with
meningitis defined by a CSF culture yielding a micro-
organism. Fourth, CrCl rate can be affected by certain
drugs, such as cimetidine [30] and trimethoprim [31],
that stimulate tubular secretion of creatinine. No such
drugs were administered in our cohort.Conclusions
Half of ICU patients with community-acquired acute
infectious meningitis have high CrCl, which, in many
cases, may persist for several days. High CrCl can be
ruled out when a value of the Cockcroft-Gault formula
is under a threshold of 101 ml/min/1.73 m2 or when a
value of the simplified MDRD equation formula is
under a threshold of 108 ml/min/1.73 m2. There is a
need to assess the clinical impact of high CrCl in ICU
patients.Additional files
Additional file 1: Table S1. Formula used to determine creatinine
clearance and body surface area.
Additional file 2: Table S2. Demographic data of patients suffering
from meningitis with or without high CrCl.
Additional file 3: Table S3. Causative organisms of meningitis in
patients with or without high CrCl.Additional file 4: Figure S1. Bland and Altman analysis of 24-hr-UV/P
creatinine and the Cockcroft-Gault formula (A) and of 24-hr-UV/P
creatinine and the simplified MDRD equation (B).
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